Algipharma
Develops alginate-based drug delivery technologies and therapeutics for pharmaceutical and healthcare applications
Highlights
- New on EvolcAdded 2026-10-30
About Algipharma
AlgiPharma develops alginate oligosaccharides as drug delivery platforms, drug conjugates and standalone active pharmaceutical ingredients for conditions including cystic fibrosis, COPD and infectious diseases. Its technology is designed for inhaled, oral, intravenous and topical formulations.
The company is a clinical-stage biopharmaceutical developer. Its technology has been used in clinical trials, and it develops and manufactures alginate oligosaccharides.
AlgiPharma AS is registered in Sandvika, Norway. The company materials describe operations through subsidiaries in Norway and Australia; they also state that AlgiPharma was founded in 2006.
Product: Alginate oligosaccharide drug delivery platforms, drug conjugates and standalone therapeutic ingredients.
Jobs at Algipharma
More biotech & pharma companies
Amicoat
Antimicrobial peptide coating technology for medical device makers aiming to reduce hospital-acquired infectionsNew on EvolcArctic Bioscience
Biotech developing marine membrane lipid ingredients from herring roe for pharma and nutraceutical buyersNew on EvolcArcticzymes
Enzyme supplier for molecular research, diagnostics and biomanufacturing, including cold-adapted and salt-active nucleasesNew on EvolcArtbio
Develops alpha radioligand cancer therapies for patients; lead prostate cancer candidate AB001 is in Phase 1 trialsNew on EvolcBenchmark Genetics Norway
Supplies salmon ova and genetics services to aquaculture producers worldwideNew on EvolcBio-Me
QPCR-based microbiome profiling for researchers, pharma and consumer health companies, with diagnostic test developmentNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Tag Manager
- Google Universal Analytics
- PHP
- WordPress
- jQuery
- nginx